The global neurovascular thrombectomy device market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of patients suffering from stroke and other neurological disorders, which in turn will lead to an increase in demand for neurovascular thrombectomy devices. The global neurovascular thrombectomy device market has been segmented on the basis of type, application and region. On the basis of type, it has been segmented into mechanical/fragmentation thrombectomy devices, stent retrievers, basket/brush retrievers, coil retrievers and aspiration thrombectomy devices. On the basis of application it has been segmented into hospitals and surgical centers as well as ambulatory surgical centers. On the basis of region it has been segmented into North America (US, Canada), Latin America (Brazil), Europe (Germany), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- Increasing prevalence of stroke and other neurological disorders will drive the Neurovascular Thrombectomy Device market.
- Increasing number of hospitals and healthcare facilities will drive the Neurovascular Thrombectomy Device market.
- Increasing number of neurosurgeons will drive the Neurovascular Thrombectomy Device market.
- Growing geriatric population in developing countries.
Industry Growth Insights published a new data on “Neurovascular Thrombectomy Device Market”. The research report is titled “Neurovascular Thrombectomy Device Market research by Types (Mechanical/Fragmentation Thrombectomy Devices, Stent Retrievers, Basket/Brush Retrievers, Coil Retrievers, Aspiration Thrombectomy Devices, Rheolytic/Hydrodynamic Thrombectomy Devices, Ultrasonic Thrombectomy Devices), By Applications (Hospitals and Surgical Centers, Ambulatory Surgical Centers, Research Laboratories & Academic Institutes, Others), By Players/Companies Stryker Corporation (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), Teleflex Incorporated (U.S.)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neurovascular Thrombectomy Device Market Research Report
By Type
Mechanical/Fragmentation Thrombectomy Devices, Stent Retrievers, Basket/Brush Retrievers, Coil Retrievers, Aspiration Thrombectomy Devices, Rheolytic/Hydrodynamic Thrombectomy Devices, Ultrasonic Thrombectomy Devices
By Application
Hospitals and Surgical Centers, Ambulatory Surgical Centers, Research Laboratories & Academic Institutes, Others
By Companies
Stryker Corporation (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), Teleflex Incorporated (U.S.)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Neurovascular Thrombectomy Device Market Report Segments:
The global Neurovascular Thrombectomy Device market is segmented on the basis of:
Types
Mechanical/Fragmentation Thrombectomy Devices, Stent Retrievers, Basket/Brush Retrievers, Coil Retrievers, Aspiration Thrombectomy Devices, Rheolytic/Hydrodynamic Thrombectomy Devices, Ultrasonic Thrombectomy Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Surgical Centers, Ambulatory Surgical Centers, Research Laboratories & Academic Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stryker Corporation (U.S.)
- Medtronic plc (Ireland)
- Boston Scientific Corporation (U.S.)
- Johnson & Johnson (U.S.)
- Terumo Corporation (Japan)
- Penumbra, Inc. (U.S.)
- Spectranetics Corporation (U.S.)
- Edwards Lifesciences Corporation (U.S.)
- Argon Medical Devices, Inc. (U.S.)
- Teleflex Incorporated (U.S.)
Highlights of The Neurovascular Thrombectomy Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mechanical/Fragmentation Thrombectomy Devices
- Stent Retrievers
- Basket/Brush Retrievers
- Coil Retrievers
- Aspiration Thrombectomy Devices
- Rheolytic/Hydrodynamic Thrombectomy Devices
- Ultrasonic Thrombectomy Devices
- By Application:
- Hospitals and Surgical Centers
- Ambulatory Surgical Centers
- Research Laboratories & Academic Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neurovascular Thrombectomy Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A neurovascular thrombectomy device is a medical device that is used to remove blood clots from the brain or other areas of the body.
Some of the key players operating in the neurovascular thrombectomy device market are Stryker Corporation (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), Teleflex Incorporated (U.S.).
The neurovascular thrombectomy device market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurovascular Thrombectomy Device Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neurovascular Thrombectomy Device Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neurovascular Thrombectomy Device Market - Supply Chain
4.5. Global Neurovascular Thrombectomy Device Market Forecast
4.5.1. Neurovascular Thrombectomy Device Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neurovascular Thrombectomy Device Market Size (000 Units) and Y-o-Y Growth
4.5.3. Neurovascular Thrombectomy Device Market Absolute $ Opportunity
5. Global Neurovascular Thrombectomy Device Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Neurovascular Thrombectomy Device Market Size and Volume Forecast by Type
5.3.1. Mechanical/Fragmentation Thrombectomy Devices
5.3.2. Stent Retrievers
5.3.3. Basket/Brush Retrievers
5.3.4. Coil Retrievers
5.3.5. Aspiration Thrombectomy Devices
5.3.6. Rheolytic/Hydrodynamic Thrombectomy Devices
5.3.7. Ultrasonic Thrombectomy Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Neurovascular Thrombectomy Device Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Neurovascular Thrombectomy Device Market Size and Volume Forecast by Application
6.3.1. Hospitals and Surgical Centers
6.3.2. Ambulatory Surgical Centers
6.3.3. Research Laboratories & Academic Institutes
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Neurovascular Thrombectomy Device Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Neurovascular Thrombectomy Device Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Neurovascular Thrombectomy Device Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Neurovascular Thrombectomy Device Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Neurovascular Thrombectomy Device Demand Share Forecast, 2019-2026
9. North America Neurovascular Thrombectomy Device Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Neurovascular Thrombectomy Device Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Neurovascular Thrombectomy Device Market Size and Volume Forecast by Application
9.4.1. Hospitals and Surgical Centers
9.4.2. Ambulatory Surgical Centers
9.4.3. Research Laboratories & Academic Institutes
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Neurovascular Thrombectomy Device Market Size and Volume Forecast by Type
9.7.1. Mechanical/Fragmentation Thrombectomy Devices
9.7.2. Stent Retrievers
9.7.3. Basket/Brush Retrievers
9.7.4. Coil Retrievers
9.7.5. Aspiration Thrombectomy Devices
9.7.6. Rheolytic/Hydrodynamic Thrombectomy Devices
9.7.7. Ultrasonic Thrombectomy Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Neurovascular Thrombectomy Device Demand Share Forecast, 2019-2026
10. Latin America Neurovascular Thrombectomy Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Neurovascular Thrombectomy Device Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Neurovascular Thrombectomy Device Market Size and Volume Forecast by Application
10.4.1. Hospitals and Surgical Centers
10.4.2. Ambulatory Surgical Centers
10.4.3. Research Laboratories & Academic Institutes
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Neurovascular Thrombectomy Device Market Size and Volume Forecast by Type
10.7.1. Mechanical/Fragmentation Thrombectomy Devices
10.7.2. Stent Retrievers
10.7.3. Basket/Brush Retrievers
10.7.4. Coil Retrievers
10.7.5. Aspiration Thrombectomy Devices
10.7.6. Rheolytic/Hydrodynamic Thrombectomy Devices
10.7.7. Ultrasonic Thrombectomy Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Neurovascular Thrombectomy Device Demand Share Forecast, 2019-2026
11. Europe Neurovascular Thrombectomy Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Neurovascular Thrombectomy Device Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Neurovascular Thrombectomy Device Market Size and Volume Forecast by Application
11.4.1. Hospitals and Surgical Centers
11.4.2. Ambulatory Surgical Centers
11.4.3. Research Laboratories & Academic Institutes
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Neurovascular Thrombectomy Device Market Size and Volume Forecast by Type
11.7.1. Mechanical/Fragmentation Thrombectomy Devices
11.7.2. Stent Retrievers
11.7.3. Basket/Brush Retrievers
11.7.4. Coil Retrievers
11.7.5. Aspiration Thrombectomy Devices
11.7.6. Rheolytic/Hydrodynamic Thrombectomy Devices
11.7.7. Ultrasonic Thrombectomy Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Neurovascular Thrombectomy Device Demand Share, 2019-2026
12. Asia Pacific Neurovascular Thrombectomy Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Neurovascular Thrombectomy Device Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Neurovascular Thrombectomy Device Market Size and Volume Forecast by Application
12.4.1. Hospitals and Surgical Centers
12.4.2. Ambulatory Surgical Centers
12.4.3. Research Laboratories & Academic Institutes
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Neurovascular Thrombectomy Device Market Size and Volume Forecast by Type
12.7.1. Mechanical/Fragmentation Thrombectomy Devices
12.7.2. Stent Retrievers
12.7.3. Basket/Brush Retrievers
12.7.4. Coil Retrievers
12.7.5. Aspiration Thrombectomy Devices
12.7.6. Rheolytic/Hydrodynamic Thrombectomy Devices
12.7.7. Ultrasonic Thrombectomy Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Neurovascular Thrombectomy Device Demand Share, 2019-2026
13. Middle East & Africa Neurovascular Thrombectomy Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Neurovascular Thrombectomy Device Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Neurovascular Thrombectomy Device Market Size and Volume Forecast by Application
13.4.1. Hospitals and Surgical Centers
13.4.2. Ambulatory Surgical Centers
13.4.3. Research Laboratories & Academic Institutes
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Neurovascular Thrombectomy Device Market Size and Volume Forecast by Type
13.7.1. Mechanical/Fragmentation Thrombectomy Devices
13.7.2. Stent Retrievers
13.7.3. Basket/Brush Retrievers
13.7.4. Coil Retrievers
13.7.5. Aspiration Thrombectomy Devices
13.7.6. Rheolytic/Hydrodynamic Thrombectomy Devices
13.7.7. Ultrasonic Thrombectomy Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Neurovascular Thrombectomy Device Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Neurovascular Thrombectomy Device Market: Market Share Analysis
14.2. Neurovascular Thrombectomy Device Distributors and Customers
14.3. Neurovascular Thrombectomy Device Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Stryker Corporation (U.S.)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic plc (Ireland)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific Corporation (U.S.)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Johnson & Johnson (U.S.)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Terumo Corporation (Japan)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Penumbra, Inc. (U.S.)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Spectranetics Corporation (U.S.)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Edwards Lifesciences Corporation (U.S.)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Argon Medical Devices, Inc. (U.S.)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Teleflex Incorporated (U.S.)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18